126 related articles for article (PubMed ID: 12459120)
21. Comparative study of the inductive effect of two psychomoderators--tetrabamate and complexe 1656--and of phenobarbital on liver microsomal enzymes in rats.
Medilanski P; Corthay J; Benakis A
Arzneimittelforschung; 1979; 29(9):1398-401. PubMed ID: 583248
[TBL] [Abstract][Full Text] [Related]
22. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.
Lucena MI; Andrade RJ; Fernández MC; Pachkoria K; Pelaez G; Durán JA; Villar M; Rodrigo L; Romero-Gomez M; Planas R; Barriocanal A; Costa J; Guarner C; Blanco S; Navarro JM; Pons F; Castiella A; Avila S;
Hepatology; 2006 Oct; 44(4):850-6. PubMed ID: 17006920
[TBL] [Abstract][Full Text] [Related]
23. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe.
Teschke R; Glass X; Schulze J; Eickhoff A
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):270-80. PubMed ID: 22189691
[TBL] [Abstract][Full Text] [Related]
24. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
[TBL] [Abstract][Full Text] [Related]
25. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
[TBL] [Abstract][Full Text] [Related]
26. Herbal hepatotoxicity: a tabular compilation of reported cases.
Teschke R; Wolff A; Frenzel C; Schulze J; Eickhoff A
Liver Int; 2012 Nov; 32(10):1543-56. PubMed ID: 22928722
[TBL] [Abstract][Full Text] [Related]
27. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
[No Abstract] [Full Text] [Related]
28. [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
[TBL] [Abstract][Full Text] [Related]
29. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement.
Teschke R; Frenzel C; Wolff A; Herzog J; Glass X; Schulze J; Eickhoff A
Ann Hepatol; 2012; 11(4):500-12. PubMed ID: 22700632
[TBL] [Abstract][Full Text] [Related]
30. Clinical and causality assessment in herbal hepatotoxicity.
Teschke R; Schwarzenboeck A; Eickhoff A; Frenzel C; Wolff A; Schulze J
Expert Opin Drug Saf; 2013 May; 12(3):339-66. PubMed ID: 23458441
[TBL] [Abstract][Full Text] [Related]
31. [Effect of tetrabamate, phenobarbital and a small quantity of alcohol on certain perceptive-motor aspects in connection with automobile driving].
Michiels W; Fryc O; Meyer JJ
Schweiz Med Wochenschr; 1978 Apr; 108(17):640-6. PubMed ID: 644278
[TBL] [Abstract][Full Text] [Related]
32. [Atrium 300 hepatitis. A new case].
Cayla JM; Fandi L; Arnould P; Degott C; Gouffier E
Presse Med; 1995 Nov; 24(35):1665. PubMed ID: 8545391
[No Abstract] [Full Text] [Related]
33. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
34. [Tetrabamate in the treatment of agoraphobia].
Iruela Cuadrado LM; García Páez JM
Med Clin (Barc); 1988 Nov; 91(18):717. PubMed ID: 3230993
[No Abstract] [Full Text] [Related]
35. [Tetrabamate and a benefit-risk ratio].
Isabel Lucena M; Andrade RJ; García-Ruiz E; Madurga M
Med Clin (Barc); 2002 Apr; 118(12):477. PubMed ID: 11958767
[No Abstract] [Full Text] [Related]
36. Flutamide-induced hepatotoxicity: report of a case series.
García Cortés M; Andrade RJ; Lucena MI; Sánchez Martínez H; Fernández MC; Ferrer T; Martín-Vivaldi R; Peláez G; Suárez F; Romero-Gómez M; Montero JL; Fraga E; Camargo R; Alcántara R; Pizarro MA; García-Ruiz E; Rosemary-Gómez M
Rev Esp Enferm Dig; 2001 Jul; 93(7):423-32. PubMed ID: 11685939
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses].
Ghozzi H; Hakim A; Sahnoun Z; Ben Mahmoud L; Atheymen R; Hammami S; Zeghal K
Rev Neurol (Paris); 2011; 167(8-9):600-6. PubMed ID: 21492891
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.
Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Sarganas G; Kreutz R; Garbe E
Br J Clin Pharmacol; 2015 Jun; 79(6):988-99. PubMed ID: 25444550
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
40. Pregabalin-induced hepatotoxicity.
Sendra JM; Junyent TT; Pellicer MJ
Ann Pharmacother; 2011 Jun; 45(6):e32. PubMed ID: 21652790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
